Literature DB >> 1826688

Activation of p34cdc2 kinase by cyclin A.

L M Roy1, K I Swenson, D H Walker, B G Gabrielli, R S Li, H Piwnica-Worms, J L Maller.   

Abstract

Functional clam cyclin A and B proteins have been produced using a baculovirus expression system. Both cyclin A and B can induce meiosis I and meiosis II in Xenopus in the absence of protein synthesis. Half-maximal induction occurs at 50 nM for cyclin A and 250 nM for cyclin B. Addition of 25 nM cyclin A to activated Xenopus egg extracts arrested in the cell cycle by treatment with RNase or emetine activates cdc2 kinase to the normal metaphase level and stimulates one oscillatory cell cycle. High levels of cyclin A cause marked hyperactivation of cdc2 kinase and a stable arrest at the metaphase point in the cell cycle. Kinetic studies demonstrate the concentration of cyclin A added does not affect the 10 min lag period required for kinase activation or the timing of maximal activity, but does control the rate of deactivation of cdc2 kinase during exit from mitosis. In addition, exogenous clam cyclin A inhibits the degradation of both A- and B-type endogenous Xenopus cyclins. These results define a system for investigating the biochemistry and regulation of cdc2 kinase activation by cyclin A.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826688      PMCID: PMC2288969          DOI: 10.1083/jcb.113.3.507

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  40 in total

1.  The role of cyclin synthesis and degradation in the control of maturation promoting factor activity.

Authors:  A W Murray; M J Solomon; M W Kirschner
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

2.  The clam embryo protein cyclin A induces entry into M phase and the resumption of meiosis in Xenopus oocytes.

Authors:  K I Swenson; K M Farrell; J V Ruderman
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

3.  The product of the mos proto-oncogene as a candidate "initiator" for oocyte maturation.

Authors:  N Sagata; I Daar; M Oskarsson; S D Showalter; G F Vande Woude
Journal:  Science       Date:  1989-08-11       Impact factor: 47.728

4.  Translation of cyclin mRNA is necessary for extracts of activated xenopus eggs to enter mitosis.

Authors:  J Minshull; J J Blow; T Hunt
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

5.  Dephosphorylation and activation of Xenopus p34cdc2 protein kinase during the cell cycle.

Authors:  J Gautier; T Matsukawa; P Nurse; J Maller
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

6.  Mammalian growth-associated H1 histone kinase: a homolog of cdc2+/CDC28 protein kinases controlling mitotic entry in yeast and frog cells.

Authors:  T A Langan; J Gautier; M Lohka; R Hollingsworth; S Moreno; P Nurse; J Maller; R A Sclafani
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

7.  The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis.

Authors:  W G Dunphy; L Brizuela; D Beach; J Newport
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

8.  Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos.

Authors:  S A Maxwell; R B Arlinghaus
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

9.  Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes.

Authors:  N Sagata; M Oskarsson; T Copeland; J Brumbaugh; G F Vande Woude
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

10.  The role of cyclin B in meiosis I.

Authors:  J M Westendorf; K I Swenson; J V Ruderman
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

View more
  38 in total

Review 1.  Triggering the all-or-nothing switch into mitosis.

Authors:  P H O'Farrell
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

2.  Identification of the domains in cyclin A required for binding to, and activation of, p34cdc2 and p32cdk2 protein kinase subunits.

Authors:  H Kobayashi; E Stewart; R Poon; J P Adamczewski; J Gannon; T Hunt
Journal:  Mol Biol Cell       Date:  1992-11       Impact factor: 4.138

3.  cdc25+ encodes a protein phosphatase that dephosphorylates p34cdc2.

Authors:  M S Lee; S Ogg; M Xu; L L Parker; D J Donoghue; J L Maller; H Piwnica-Worms
Journal:  Mol Biol Cell       Date:  1992-01       Impact factor: 4.138

4.  Phosphorylation of Xenopus cyclins B1 and B2 is not required for cell cycle transitions.

Authors:  T Izumi; J L Maller
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Enforcing temporal control of maternal mRNA translation during oocyte cell-cycle progression.

Authors:  Karthik Arumugam; Yiying Wang; Linda L Hardy; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2009-12-03       Impact factor: 11.598

6.  Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events.

Authors:  J S Kang; R S Krauss
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

7.  MAPK inactivation is required for the G2 to M-phase transition of the first mitotic cell cycle.

Authors:  A Abrieu; D Fisher; M N Simon; M Dorée; A Picard
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

8.  Multiple forms of maturation-promoting factor in unfertilized Xenopus eggs.

Authors:  J Kuang; J E Penkala; C L Ashorn; D A Wright; G F Saunders; P N Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

9.  Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells.

Authors:  T Kamalati; D Davies; J Titley; M R Crompton
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

10.  Oncogenic ras triggers the activation of 42-kDa mitogen-activated protein kinase in extracts of quiescent Xenopus oocytes.

Authors:  E K Shibuya; A J Polverino; E Chang; M Wigler; J V Ruderman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.